M8E Stock Overview
Montea NV is a public regulated real estate company under Belgian law (GVV/SIR) that specializes in logistics real estate in Belgium, the Netherlands, France, and Germany. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 4/6 |
Financial Health | 2/6 |
Dividends | 6/6 |
Rewards
Risk Analysis
Montea Comm. VA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €62.60 |
52 Week High | €87.50 |
52 Week Low | €62.60 |
Beta | 0.58 |
11 Month Change | -8.88% |
3 Month Change | -22.33% |
1 Year Change | -17.74% |
33 Year Change | -50.71% |
5 Year Change | -20.25% |
Change since IPO | 87.28% |
Recent News & Updates
Recent updates
Shareholder Returns
M8E | DE Industrial REITs | DE Market | |
---|---|---|---|
7D | -4.0% | 0% | 0% |
1Y | -17.7% | 0% | 0% |
Return vs Industry: M8E underperformed the German Industrial REITs industry which returned -11.6% over the past year.
Return vs Market: M8E underperformed the German Market which returned 7.1% over the past year.
Price Volatility
M8E volatility | |
---|---|
M8E Average Weekly Movement | 3.1% |
Industrial REITs Industry Average Movement | 0% |
Market Average Movement | 0% |
10% most volatile stocks in DE Market | 0% |
10% least volatile stocks in DE Market | 0% |
Stable Share Price: M8E has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: M8E's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1977 | 58 | Jo De Wolf | www.montea.com |
Montea NV is a public regulated real estate company under Belgian law (GVV/SIR) that specializes in logistics real estate in Belgium, the Netherlands, France, and Germany. The company is a benchmark player in this market. Montea literally offers its customers the space to grow through versatile and innovative property solutions.
Montea Comm. VA Fundamentals Summary
M8E fundamental statistics | |
---|---|
Market cap | €1.45b |
Earnings (TTM) | €154.30m |
Revenue (TTM) | €133.86m |
9.4x
P/E Ratio10.8x
P/S RatioIs M8E overvalued?
See Fair Value and valuation analysisEarnings & Revenue
M8E income statement (TTM) | |
---|---|
Revenue | €133.86m |
Cost of Revenue | €18.35m |
Gross Profit | €115.51m |
Other Expenses | -€38.79m |
Earnings | €154.30m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 11, 2025
Earnings per share (EPS) | 6.74 |
Gross Margin | 86.29% |
Net Profit Margin | 115.27% |
Debt/Equity Ratio | 57.4% |
How did M8E perform over the long term?
See historical performance and comparison